Effect of vitamin D therapy on endothelial function in ischemic heart disease female patients with vitamin D deficiency or insufficiency: A primary report

Abstract

BACKGROUND: Vitamin D deficiency is associated with vascular endothelial dysfunction. We evaluated endothelial function in ischemic heart disease (IHD) patients with vitamin D deficiency or insufficiency before and after vitamin D therapy. METHODS: An uncontrolled before-after study was conducted in Isfahan, Iran on consecutive sample of female IHD patients who had undergone percutaneous coronary intervention in the preceding 6 months and/or referred with chronic stable angina. Forty patients with vitamin D deficiency or insufficiency (serum 25-hydroxy vitamin D < 20 or 20-30 ng/ml, respectively) were included and received two intramuscular injections of 300,000 IU cholecalciferol with 1 month interval. Endothelial function, assessed by measuring flow-mediated dilatation (FMD), and serum 25-hydroxy vitamin D level were measured at baseline and 1 month after the second dose of cholecalciferol. RESULTS: A total of 30 patients completed the study, age = 59.4 +/- 8.7 years; serum 25-hydroxy vitamin D = 19.0 +/- 6.5 ng/ml. After treatment, serum 25-hydroxy vitamin D was reached to > 30 ng/ml in all patients. Brachial artery diameter (mm) after ischemia increased significantly, statistically but not clinically (4.55 +/- 0.37 to 4.67 +/- 0.38, P < 0.001). Furthermore, FMD () was increased from 1.96 +/- 1.65 to 4.65 +/- 1.27 (P < 0.001). The amount of change in FMD was not significantly correlated with serum 25-hydroxy vitamin D (r = 0.038, P = 0.858). CONCLUSION: Endothelial function was improved after vitamin D therapy in IHD patients with low serum vitamin D. Controlled studies with larger sample size are required to confirm if vitamin D therapy has effects on endothelial function.